[go: up one dir, main page]

AR029898A1 - Un metodo para la preparacion de un producto citalopram purificado - Google Patents

Un metodo para la preparacion de un producto citalopram purificado

Info

Publication number
AR029898A1
AR029898A1 ARP010101210A ARP010101210A AR029898A1 AR 029898 A1 AR029898 A1 AR 029898A1 AR P010101210 A ARP010101210 A AR P010101210A AR P010101210 A ARP010101210 A AR P010101210A AR 029898 A1 AR029898 A1 AR 029898A1
Authority
AR
Argentina
Prior art keywords
citalopram
preparation
product
purified
citalopram product
Prior art date
Application number
ARP010101210A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR029898A1 publication Critical patent/AR029898A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un método para la preparacion de un producto de citalopram purificado en donde el producto citalopram crudo está opcionalmente sujeto a una purificacion inicial, y la base del citalopram, crudo está subsiguientemente sujeto a un proceso de destilacion en película para eliminar impurezas de reaccion de alto peso molecular; el producto de citalopram resultante es luego opcional y adicionalmente purificado, y procesado y aislado en forma de base o sal farmacéuticamente aceptable de la misma.En dicho método las impurezas de reaccion de alto peso molecular que son eliminadas comprenden formas diméricas de citalopram que tienen las formulas.1 y/o 2.
ARP010101210A 2000-12-28 2001-03-15 Un metodo para la preparacion de un producto citalopram purificado AR029898A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200001943 2000-12-28

Publications (1)

Publication Number Publication Date
AR029898A1 true AR029898A1 (es) 2003-07-23

Family

ID=8159933

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101210A AR029898A1 (es) 2000-12-28 2001-03-15 Un metodo para la preparacion de un producto citalopram purificado

Country Status (41)

Country Link
US (2) US6855834B2 (es)
EP (1) EP1181272B1 (es)
JP (1) JP2003519121A (es)
KR (1) KR100430746B1 (es)
CN (1) CN1366526A (es)
AR (1) AR029898A1 (es)
AT (2) ATE222899T1 (es)
AU (3) AU3920201A (es)
BE (2) BE1013417A6 (es)
BG (1) BG106219A (es)
BR (1) BR0106271A (es)
CA (1) CA2359810C (es)
CH (1) CH691536A5 (es)
CZ (1) CZ293140B6 (es)
DE (1) DE60100016T2 (es)
DK (1) DK1181272T3 (es)
EA (1) EA003459B1 (es)
ES (2) ES2181663T3 (es)
FI (2) FI108640B (es)
FR (1) FR2818977B1 (es)
GB (2) GB2356199B (es)
GR (1) GR20010100131A (es)
HK (1) HK1049332A1 (es)
HR (1) HRP20020005A2 (es)
HU (2) HU0101028D0 (es)
IE (2) IES20010253A2 (es)
IL (1) IL147162A0 (es)
IS (1) IS5884A (es)
IT (1) ITMI20010604A1 (es)
MX (1) MXPA01013336A (es)
NL (1) NL1017534C1 (es)
NO (1) NO313047B1 (es)
NZ (1) NZ516299A (es)
PL (1) PL353369A1 (es)
PT (1) PT1181272E (es)
SE (1) SE0103044L (es)
SK (1) SK284418B6 (es)
TR (1) TR200200018T1 (es)
UA (1) UA71635C2 (es)
WO (1) WO2001047877A2 (es)
ZA (1) ZA200110133B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
KR100604156B1 (ko) * 1999-04-14 2006-07-25 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EP1228056B1 (en) 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
HK1043129B (zh) 1999-10-25 2004-10-21 H‧隆德贝克有限公司 西酞普蘭的製備方法
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
CN1398263A (zh) 1999-12-28 2003-02-19 H·隆德贝克有限公司 制备西酞普兰的方法
HK1052512B (zh) 1999-12-30 2006-03-03 H. 隆德贝克有限公司 西酞普兰的制备方法
PL197821B1 (pl) 2000-01-14 2008-04-30 Lundbeck & Co As H Sposób wytwarzania 5-cyjanoftalidu
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
TR200202166T2 (tr) 2000-03-13 2002-12-23 H. Lndbeck A/S Sitalopramın preparasyon metodu
NZ521204A (en) * 2000-03-13 2004-03-26 H Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)- 1,3-dihydroisobenzofurans for preparing citalopram, an anti depressant
PT1265882E (pt) 2000-03-14 2004-06-30 Lundbeck & Co As H Metodo para preparacao de citalopram; composto e citalopram
HUP0300134A2 (en) * 2000-03-16 2003-05-28 Lundbeck & Co As H Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
IL144817A0 (en) 2000-08-18 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
IL147226A (en) 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure citalopram
SK284418B6 (sk) 2000-12-28 2005-04-01 H. Lundbeck A/S Spôsob výroby citalopramu
GB2376945A (en) * 2001-06-27 2002-12-31 Cipla Ltd Citalopram preparation
AU2003222435A1 (en) 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
ES2194597B2 (es) * 2002-01-25 2004-08-01 Esteve Quimica, S.A. Procedimiento para la obtencion de citalopram.
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135959C (es) 1964-12-23
GB1143703A (es) 1965-03-18
DE1619713A1 (de) * 1967-03-29 1970-12-17 Leybold Heraeus Gmbh & Co Kg Vorrichtung zur Vakuum- und Kurzwegdestillation
DE2135085C3 (de) 1971-07-14 1981-12-03 Basf Ag, 6700 Ludwigshafen Verfahren zur Wiedergewinnung von Caprolactam aus einem Gemisch, das Caprolactam und dessen Oligomere enthält
DE2442426C2 (de) 1974-09-05 1983-04-07 Bayer Ag, 5090 Leverkusen Diisocyanatodiketene, Verfahren zu deren Herstellung und deren Verwendung
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
IT8020902A0 (it) 1980-03-25 1980-03-25 Snia Viscosa Procedimento ed apparecchiatura per la separazione continua per via termica di miscele liquide dicomposti termolabili.
JPS6082101A (ja) 1983-10-13 1985-05-10 Mitsui Toatsu Chem Inc 高沸点重合性化合物の薄膜蒸留による精製方法
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
FR2656305B1 (fr) 1989-12-22 1992-04-10 Norsolor Sa Procede de purification du (meth)acrylate de glycidyle.
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
US5582692A (en) 1994-10-07 1996-12-10 Artisan Industries, Inc. Method for the purification of vitamin E
DE69725717T2 (de) 1996-05-21 2004-07-29 Exxonmobil Chemical Patents Inc., Baytown Reinigung von glycidylestern durch dünnschichtverdampfung
US6136991A (en) * 1996-05-21 2000-10-24 Exxon Chemical Patents Inc. Glycidyl ester adducts having increased glass transition temperatures
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
SK283309B6 (sk) 1997-07-08 2003-05-02 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
DE19734673A1 (de) 1997-08-11 1999-02-18 Rwe Dea Ag Verfahren zur Herstellung von metallfreien Guerbetalkoholen
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
ES2149734T3 (es) 1997-11-11 2003-02-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
EP0965593B2 (en) 1998-06-19 2008-12-03 Shin-Etsu Chemical Co., Ltd. Distillation of (meth)acryloxybearing alkoxysilane
WO2000023431A1 (en) * 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
EP1140886B1 (en) 1998-12-23 2003-04-02 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
KR100604156B1 (ko) 1999-04-14 2006-07-25 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조방법
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EP1228056B1 (en) 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
IL147226A (en) 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure citalopram
SK284418B6 (sk) 2000-12-28 2005-04-01 H. Lundbeck A/S Spôsob výroby citalopramu
US6781003B1 (en) * 2003-06-09 2004-08-24 Aurobindo Pharma Ltd. Preparation of pure citalopram

Also Published As

Publication number Publication date
IS5884A (is) 2002-06-28
PL353369A1 (en) 2003-11-17
GR20010100131A (el) 2002-10-09
ES2170733B1 (es) 2003-12-16
HU0101028D0 (en) 2001-05-28
AU750006B1 (en) 2002-07-11
WO2001047877A2 (en) 2001-07-05
GB2361697A (en) 2001-10-31
JP2003519121A (ja) 2003-06-17
HUP0102818A3 (en) 2003-07-28
SK284418B6 (sk) 2005-04-01
ITMI20010604A0 (it) 2001-03-22
CA2359810A1 (en) 2001-07-05
TR200200018T1 (tr) 2002-06-21
HK1049332A1 (zh) 2003-05-09
CA2359810C (en) 2002-11-05
GB2356199B (en) 2001-10-03
EP1181272B1 (en) 2002-08-28
EA003459B1 (ru) 2003-06-26
NZ516299A (en) 2002-12-20
NO20011272L (no) 2002-07-01
EA200200016A1 (ru) 2002-04-25
FI20011578A0 (fi) 2001-07-26
EP1181272A2 (en) 2002-02-27
CZ2001891A3 (cs) 2002-08-14
US20020087012A1 (en) 2002-07-04
DE60100016D1 (de) 2002-10-02
NO20011272D0 (no) 2001-03-13
UA71635C2 (uk) 2004-12-15
KR20020073379A (ko) 2002-09-26
CH691536A5 (de) 2001-08-15
NL1017534C1 (nl) 2001-04-26
US20030178295A1 (en) 2003-09-25
WO2001047877A3 (en) 2001-12-27
DK1181272T3 (da) 2002-12-30
BR0106271A (pt) 2002-05-21
HUP0102818A2 (hu) 2001-12-28
ZA200110133B (en) 2003-01-13
ES2181663T3 (es) 2003-03-01
GB0117095D0 (en) 2001-09-05
AU2001100399B4 (en) 2002-03-21
NO313047B1 (no) 2002-08-05
IES20010253A2 (en) 2002-03-06
DE60100016T2 (de) 2003-04-17
HRP20020005A2 (en) 2003-04-30
ITMI20010604A1 (it) 2002-09-22
IES20010632A2 (en) 2002-03-06
SE0103044D0 (sv) 2001-09-14
BE1013316A6 (fr) 2001-11-06
AU3920201A (en) 2001-07-09
US6855834B2 (en) 2005-02-15
ES2170733A1 (es) 2002-08-01
IL147162A0 (en) 2002-08-14
BE1013417A6 (fr) 2001-12-04
FI20010501A0 (fi) 2001-03-13
GB2356199A (en) 2001-05-16
FR2818977A1 (fr) 2002-07-05
GB0105981D0 (en) 2001-05-02
SE0103044L (sv) 2002-06-29
ATE222899T1 (de) 2002-09-15
BG106219A (en) 2002-08-30
KR100430746B1 (ko) 2004-05-10
HU0102818D0 (en) 2001-09-28
CZ293140B6 (cs) 2004-02-18
AU2001100399A4 (en) 2001-11-01
PT1181272E (pt) 2003-01-31
FI108640B (fi) 2002-02-28
CN1366526A (zh) 2002-08-28
AT4368U1 (de) 2001-06-25
SK18472001A3 (sk) 2002-05-09
FR2818977B1 (fr) 2003-12-05
MXPA01013336A (es) 2002-07-09

Similar Documents

Publication Publication Date Title
AR029898A1 (es) Un metodo para la preparacion de un producto citalopram purificado
ES2170732A1 (es) Procedimiento para preparar citalopram purificado
ES2150567T3 (es) Antagonistas del factor de liberacion de la corticotropina.
MX9201775A (es) Metodos y composiciones para aislar taxanos.
ATE417107T1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
AR029825A1 (es) Una composicion farmaceuticamente aceptable que comprende carvedilol o una sal del mismo farmaceuticamente aceptable, un procedimiento para la produccion de dicha composicion y utilizacion de la misma
CY1108085T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπ-2-εν-1-ονης παρασκευη και χρησης αυτων
BRPI0410685B8 (pt) processos de purificação do 1,3-propanodiol e composição
PT1274698E (pt) Perciquinina, metodo para a sua producao e sua utilizacao como medicamento
ECSP088499A (es) Nuevos compuestos de 2-amino-imidazol-4-ona y su uso en la fabricación de un medicamento para uso en el tratamiento de alteración cognitiva, enfermedad de alzheimer, neurodegeneración y demencia
ES2144143T3 (es) Proceso de purificacion para productos de hexafluoroetano.
AU5377100A (en) Process for extraction and purification of paclitaxel from natural sources
DZ3412A1 (fr) Procede ameliore de purification et de recuperation d'acetonitrile
PE103799A1 (es) Procedimiento de purificacion de mesilato de alatrofloxacino
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
AR046229A1 (es) Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura
ATE243207T1 (de) Verfahren zur herstellung von simvastatin und ihren derivaten
ATE419012T1 (de) Verwendung von 2,5-dihydroxybenzolsulfonsäure- derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion
NO20065942L (no) Gjenvinning av 2,6-naftalendiakarboksylsyre (2,6-NDA) inneholdt i polyetylennaftalat i en fremgangsmate for a fremstille diestere
DE60022960D1 (de) Verfahren zur Reinigung von S-Adenosyl-L-Methionin und zur Herstellung von pharmazeutisch verträglichen Salzen davon
DE59606725D1 (de) Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
AR001785A1 (es) Composición farmacéutica para la inhibición de producción o secreción de tnf - alfa
AR015767A1 (es) Un proceso para la preparacion de compuestos de 3-glioxamida-1h-indol-4-sustituidos o sales farmaceuticamente aceptables o derivados prodrogas y loscompuestos obtenidos por dicho proceso.
EP1207167A4 (en) PROCESS FOR PREPARING LH-RH DERIVATIVES

Legal Events

Date Code Title Description
FB Suspension of granting procedure